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Exercise bra discomfort is associated with insufficient exercise levels among 
Australian women treated for breast cancer 
Abstract 
Purpose 
Although participating in exercise is beneficial for breast cancer survivors, not being able to find a 
comfortable exercise bra can be a barrier to exercise. It is likely that side effects specific to breast cancer 
treatment exacerbate exercise bra discomfort. This study aimed to determine the relationship between 
patient characteristics, physical side effects, exercise bra discomfort and exercise behaviours. 
Methods 
Four hundred thirty-two breast cancer survivors completed an online survey related to their treatment and 
demographic background, current exercise levels, reported exercise bra discomfort and breast cancer 
treatment side effects. Patient characteristics and exercise levels were considered in a binary logistic 
regression against reporting bra discomfort to ascertain significant relationships (p < 0.05) and predictive 
value (odds ratio). Pearson's chi-square statistics was used to determine significant relationships 
between reporting a side effect and exercise bra discomfort. 
Results 
Eight out of nine physical side effects were significantly related to reporting exercise bra discomfort. 
Reporting exercise bra discomfort was significantly related to not achieving a minimal recommended 
level of exercise. 
Conclusions 
This is the first study in the scientific literature that systematically links the reporting of exercise bra 
discomfort to not achieving recommended levels of exercise. This effect of bra discomfort on exercise 
was found after controlling for age, surgery type and current treatment among a large cohort of women 
treated for breast cancer. Furthermore, results from this study suggest that physical side effects, as a 
result of surgery and treatment associated with breast cancer, are linked to experiencing bra discomfort 
during exercise. 
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Abstract 
Purpose: Although participating in exercise is beneficial for breast cancer survivors, not being 
able to find a comfortable exercise bra can be a barrier to exercise. It is likely that side effects 
specific to breast cancer treatment exacerbate exercise bra discomfort. This study aimed to 
determine the relationship between patient characteristics, physical side effects, exercise bra 
discomfort, and exercise behaviours. 
Methods: 432 breast cancer survivors completed an online survey related to their treatment 
and demographic background; current exercise levels; reported exercise bra discomfort; and 
breast cancer treatment side effects.  Patient characteristics and exercise levels were 
considered in a binary logistic regression against reporting bra discomfort to ascertain 
significant relationships (p < 0.05) and predictive value (odds ratio). Pearson’s Chi-Square 
statistics were used to determine significant relationships between reporting a side effect and 
exercise bra discomfort. 
Results: Eight out of nine physical side effects were significantly related to reporting exercise 
bra discomfort. Reporting exercise bra discomfort was significantly related to not achieving a 
minimal recommended level of exercise.   
Conclusions: This is the first study in the scientific literature that systematically links the 
reporting of exercise bra discomfort to not achieving recommended levels of exercise. This 
effect of bra discomfort on exercise was found after controlling for age, surgery type and 
current treatment among a large cohort of women treated for breast cancer. Furthermore, 
results from this study suggest that physical side effects, as a result of surgery and treatment 
associated with breast cancer, are linked to experiencing bra discomfort during exercise. 
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Introduction 
Participating in exercise has repeatedly been shown to be highly beneficial for the health and 
well-being of women who are treated for breast cancer [1-5]. Current literature indicates, 
however, that perceived barriers to exercise are associated with a reduced ability of these 
women to achieve recommended exercise levels [6-9]. Therefore, to encourage exercise 
participation among breast cancer survivors, these barriers to exercise need to be identified 
and minimised or removed [3]. In a recent study investigating 19 potential barriers to exercise, 
a lack of discipline, procrastination, being fatigued by exercise, and not being able to find a 
comfortable bra to exercise in, were ranked as the top four barriers to exercise by women 
treated for breast cancer [10].  Of these 19 barriers, bra discomfort is the highest ranked 
barrier that can be modified through an external intervention, such as by providing exercise 
bras that suit the needs of breast cancer survivors.  
Bra discomfort presents a unique challenge to women treated for breast cancer due to the 
significant physical changes to the breast and surrounding tissue as a result of breast cancer 
treatment.  Despite this, only one other study could be located which investigated the impact 
of bra discomfort on exercise levels among breast cancer survivors [10].  In that study, a 
significant proportion of respondents (70%) experienced exercise bra discomfort, although 
this was not related to weekly exercise levels or reported physical side effects. This previous 
work, however, was limited by a small sample size, and an investigation of the effect of 
exercise bra discomfort on exercise behaviour, with sufficient statistical power to control for 
confounding demographic and treatment variables, is warranted. 
Targeting patients who would benefit the most is vital when planning health or lifestyle 
interventions.  As such, a better understanding of the women more likely to report exercise bra 
discomfort is essential when identifying women most likely to benefit from interventions 
aimed at improving exercise bra design.  Patient characteristics such as age, surgery type, or 
whether the respondent was undergoing current treatment, have previously provided moderate 
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associative value when analysed with respect to potential side effects of breast cancer 
treatment [11]. We postulate that using these same patient characteristics to identify women 
who are more likely to experience exercise bra discomfort could be an informative first step in 
developing strategies to improve exercise bra comfort. These strategies may include 
improving bra design or educating women towards improving bra fit.  
Given the impact exercise barriers can have on exercise levels [6-9], and that exercise bra 
discomfort has been reported as a potential barrier to exercise [10], the effect of exercise bra 
discomfort on exercise behaviour, while controlling for the potentially participant 
characteristics should be explored. In order to develop strategies aimed at improving exercise 
bra comfort for women treated for breast cancer, a clearer understanding of the women who 
experience bra discomfort the most, as well as the physical side effects related to this bra 
discomfort is needed. Therefore, the primary aim of this study was to determine the 
relationship between exercise bra discomfort, exercise behaviours and patient characteristics 
among a large cohort of women who had been treated for breast cancer.  The secondary aim 
of this study was to assess the relationship between physical side effects of breast cancer 
treatment and exercise bra discomfort. We hypothesised that women who experience exercise 
bra discomfort do not achieve sufficient levels of exercise, after controlling for patient 
characteristics.  We also hypothesised that experiencing exercise bra discomfort is related to 
experiencing physical side effects as a result of breast cancer treatment.   
Participants and Methods 
Participants and Survey Implementation 
Breast cancer patients who had a registered email address with the Breast Cancer Network 
Australia (BCNA) Survey and Research Group or the Cancer Councils of Victoria or Western 
Australia were invited by email to complete an internet-based survey.  Of the 482 women who 
visited the initial URL, 432 completed the survey (89.6% completion rate).  This surpasses the 
calculated n = 384 required sample size (based on a conservative 50% probability of obtaining 
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statistical significance, assuming 95% confidence interval, and a 10% margin of error), thus 
providing sufficient statistical power for the following analysis [13]. Participant informed 
consent was obtained and the University Human Research Ethics Committee approved all 
data collection procedures (HREC08/326). The survey used in the present study formed part 
of a larger body of work, and details of the development, validation and content of the online 
survey instrument have been published elsewhere [11].  Survey items specific to the aims of 
the present study are described below. 
Analytical Variables 
Participant Characteristics: Participant age was an open-ended response to “What is your 
date of birth?”, calculated with respect to the survey submission date (providing age at time of 
survey completion). Following this calculation, participants were split into categories of being 
“Under 50 years old”, or “50 years and over” for the purpose of the binary logistical 
regression. Participant surgery type was assessed by a closed-ended question for which the 
responses were either a lumpectomy or mastectomy of either the right or left breast. 
Responses were not mutually exclusive, permitting participants to indicate whether they had 
undergone surgery on both breasts, or had a lumpectomy, followed by a mastectomy. 
Participants were then grouped into categories of a “lumpectomy” or a “mastectomy” for the 
binary logistic regression. 
Finally, participants were asked “Are you CURRENTLY undergoing any of the following 
treatments for your breast cancer?” with closed-ended, non-mutually exclusive, response 
categories of chemotherapy, radiotherapy and hormonal treatment.  For the purpose of the 
binary logistic regression, participants were divided into categories of “currently undergoing 
treatment” versus “finished treatment”. Women who were still taking any medication for their 
breast cancer were classified as “currently undergoing treatment”. Women were also asked the 
date of their “last treatment ever” if they had finished treatment. The difference between the 
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survey completion date and treatment completion date was calculated to give a time since 
treatment completion at the time of survey completion.  
Side Effects: Physical side effects deemed to potentially have a direct effect on bra discomfort 
included lymphoedema, broken and painful ribs, weight gain, shoulder limitations, aching 
muscles, hot flushes, burning, sensitive skin or chafing, pain, and muscular chest wall pain.  
Participants were asked to rate their experience of each of these side effects on a 5-point 
Likert scale from none (1) to severe (5). For the purpose of binary logistic regressions, women 
were divided into categories of “No symptom experience” (Likert response = 1) versus “Any 
level of experience” (Likert response = 2-5). 
Bra Discomfort: The exercise bra discomfort question was a direct, closed-ended response 
item which queried “Do parts of the bra you wear during exercise cause you discomfort?”, to 
which participants responded either “Yes” or “No”. 
Exercise Levels: Recreational exercise levels were assessed using the Recreational Activities 
domain of the World Health Organisation’s (WHO) Global Physical Activity Questionnaire 
Version 2 (GPAQ2) [14]. Based on GPAQ2 analysis guidelines, respondents were then 
classified into those who met the GPAQ2 threshold for achieving moderate or high levels of 
exercise and those who achieved low levels or no exercise. These classifications included any 
combination of moderate or vigorous intensity exercise resulting in ≥ 600 MET-minutes a 
week; or ≥ 3 days/week of vigorous intensity exercise for ≥ 20 minutes a day; or ≥ 5 
days/week of moderate intensity exercise or walking for ≥ 30 minutes a day, as per GPAQ2 
guidelines. [14] Achieving moderate or vigorous exercise as identified by GPAQ2 is also 
equivalent to meeting the WHO’s recommendation of 150 weekly minutes of moderate 
exercise, or 75 weekly minutes of vigorous exercise, or an equivalent combination of both 
[15]. For the purpose of the binary logistic regression analysis, women who achieved 
moderate or high levels of exercise were deemed as “sufficiently active” whereas women who 
achieved only low levels or no level of exercise were deemed as “insufficiently active”. 
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Statistical Treatment 
Patient Characteristics, Exercise Levels and Exercise Bra Discomfort: Exercise bra 
discomfort was considered in a binary logistic regression against patient characteristics and 
exercise levels to ascertain any significant relationships. Whether a participant reported 
experiencing bra discomfort (none versus any level of discomfort) was inserted as a dependent 
variable against the independent variables of age (< 50 years versus ≥ 50 years), type of 
surgery (lumpectomy versus mastectomy), whether women were currently undergoing 
treatment (current treatment versus finished treatment), and exercise levels (sufficiently active 
versus insufficiently active).  This method of analysis has been previously employed in a 
cross-sectional survey data analysis with this population [11, 16], and ensures each 
independent variable is analysed while controlling for the other three independent variables.  
Side Effects and Exercise Bra Discomfort: Whether a participant reported a side effect (none 
versus any) was analysed by a 2x2 cross-tabulation relative to whether the participant reported 
exercise bra discomfort in response to direct questioning (Yes/No). Relationship significance 
was assessed using a Pearson Chi-square test of independence (p < 0.05).  All statistical 
analyses were completed using SPSS for Windows software (Version 17.0, SPSS Inc, 
Chicago, USA). 
Results 
Sample Overview 
Participants were 432 women who had been treated for breast cancer, aged between 23-77 
years (mean 53.3 ± 9.8 years; see Table 1).  Table 1 provides information on the participant’s 
self-reported health status, location, age, and exercise levels with comparisons to Australian 
population data.  The age spread of the sample was generally lower than the age of the wider 
Australian breast cancer population, which may skew results towards a younger breast cancer 
population. Despite this, the self-reported health status of the participants was similar to the 
general Australian female population; and the survey sample was spread across Australian 
8 
 
States and Territories in similar proportions to the wider breast cancer population, with the 
exception of the Australian Capital Territory, which formed 10% of the sample and only 2% 
of the national spread. The proportion of women deemed sufficiently active in the survey 
sample was very comparable to an age-matched general Australian female population (36.5% 
vs. 37.6%).  
One hundred and eighty eight women had under gone a lumpectomy during treatment for their 
breast cancer, 241 women had undergone a mastectomy, and 3 women reported no surgery 
(43.5%, 55.8% and 0.7%, respectively; see Table 2).   None of the women had differing 
procedures on both breasts, and the mastectomy classification included women who had a 
lumpectomy followed by a mastectomy. Two hundred and thirty nine women were currently 
undergoing treatment (or still taking medication for their breast cancer), 148 women finished 
all treatment, and 45 women did not respond to the question (55.3% and 34.3% and 10.4%, 
respectively; see Table 2). Only 158 women (36.5%) were considered sufficiently active, 
which is close to the percentage of sufficiently active women in an age-matched general 
Australian female population (37.6%; see Table 1)[34]. Exercise data were missing for nine 
participants. In all categories, missing data were treated using listwise deletion, and although 
this resulted in data loss of up to 13%, this approach was deemed appropriate to provide 
unbiased parameter estimates. 
Patient Characteristics, Exercise Levels and Exercise Bra Discomfort  
Among respondents aged 50 years and over, the proportion of women reporting bra 
discomfort (28%) was lower than the proportion who reported no bra discomfort (36%). The 
same trend was observed to a smaller extent among women under 50 years old (15% reporting 
discomfort; 17% reporting no discomfort). Among both lumpectomy and mastectomy groups, 
the same trend was observed again, whereby the proportion of women reporting bra 
discomfort (18% lumpectomy; 25% mastectomy) was lower than the proportions of women 
reporting no bra discomfort (24% and 28% respectively). This trend was also observed in 
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current treatment groups, whereby the proportion of women reporting bra discomfort (25% 
current treatment; 14% finished all treatment) was lower than the proportions of women 
reporting no bra discomfort (29% and 19% respectively). However, the trend was reversed 
among insufficiently active respondents, whereby the proportion of women reporting bra 
discomfort (31%) was greater than the proportion who reported no bra discomfort (29%). 
Consistent with these sample proportion observations, none of the patient characteristics of 
age, undergoing current treatment, or surgery type was significantly related to whether a 
participant reported experiencing exercise bra discomfort (see Table 3).  However, reporting 
exercise bra discomfort was significantly related to a participant being sufficiently active. 
Specifically, women who reported exercise bra discomfort were less likely to be sufficiently 
active, while controlling for age, time post treatment and surgery type (OR 2.04; 1.32 – 3.16 
95% CI; p = 0.04).   
Side Effects and Exercise Bra Discomfort 
The most commonly reported physical side effects were hot flushes (n = 257), aching muscles 
(n = 242), shoulder limitations (n = 190), and pain (n = 185). Across all physical side effects 
except hot flushes, the proportion of women reporting exercise bra discomfort was greater 
than the proportion of women not reporting this discomfort (see Figure 1). Also with the 
exception of hot flushes, all of the physical side effects reported by the respondents were 
significantly related to exercise bra discomfort (Pearson Chi-Square statistic; p < 0.05).  
Discussion 
As exercise bra discomfort has been identified as a significant barrier to exercise for women 
treated for breast cancer [10], this study aimed to increase the body of knowledge in this 
sparse area of research by determining whether any relationships existed between patient 
characteristics, exercise levels, and exercise bra discomfort.  In agreement with our first 
hypothesis, women who experienced exercise bra discomfort were more likely to not achieve 
sufficient levels of exercise, after controlling for patient characteristics.  In agreement with 
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our second hypothesis, results from this study suggest that the physical side effects 
experienced as a result of surgery and treatment associated with breast cancer are linked to 
experiencing bra discomfort during exercise.  The implications of these unique findings are 
discussed below. 
Exercise Bra Discomfort and Exercise Levels 
To maintain overall health, the WHO recommends adults aged 18–64 years should do at least 
150 minutes of moderate-intensity aerobic physical activity throughout the week; or do at 
least 75 minutes of vigorous-intensity aerobic physical activity throughout the week; or an 
equivalent combination of moderate- and vigorous-intensity activity [15]. Within this study, 
irrespective of age, current treatment or type of surgery, women who reported bra discomfort 
were significantly less likely to achieve the minimum recommended level of exercise.  We 
postulate that this result implies that the level of bra discomfort experienced by a respondent 
was sufficient to impede that respondent’s ability to achieve these recommended levels of 
exercise. This finding is of concern given the well-established benefits of exercise for this 
cohort, and the potential for this barrier to be alleviated or reduced by providing more 
effective and comfortable exercise bra designs, which are specific to the needs of breast 
cancer survivors.  The specific exercise bra design needs of breast cancer survivors are likely 
linked to the side effects of their treatment, and so an investigation into the relationship 
between treatment side effects and exercise bra discomfort was also warranted.  The present 
study found that, with the exception of hot flushes, all the reported physical side effects 
associated with respondents’ breast cancer treatments were significantly related to the 
reporting of exercise bra discomfort. 
Side Effects and Bra Discomfort 
Surgical Side Effects 
Surgery for breast cancer is associated with considerable short and long-term morbidity, 
which may include lymphoedema, shoulder limitations, and pain [17, 18]. Upper-body 
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morbidity, which encompasses both lymphoedema and shoulder limitations, is a severe and 
chronic condition affecting 19-54% of breast cancer patients even up to 3 years post treatment 
[19]. Although outcomes are variable, the more extensive surgeries, such as axillary 
dissections and accompanying radiation- and chemo- therapies, are linked to the development 
of upper body morbidities. Many women who undergo breast surgery also suffer from ill-
defined pain syndromes [20]. Pain that is a direct consequence of surgery can be nociceptive 
(resulting from injury to ligament or muscle); or neuropathic (resulting from injury to the 
nerves innervating the region), and affects 20% to 75% of women following a mastectomy 
[17, 21]. Nociceptive pain usually resolves as the damaged tissues heal, whereas neuropathic 
pain may develop into a chronic syndrome [21]. Of particular relevance to bra designs for 
women following surgery for breast cancer is the development of neuroma pain, a chronic 
neuropathic pain arising from peripheral nerves being severed or injured and entrapped within 
scar tissue. These scars can cause spontaneous pain and severe mechanosensitivity [21], 
which can be exacerbated by both breast motion and contact of the bra over the scar tissue.   
The present study found reporting lymphoedema, shoulder limitations, aching muscles, pain, 
and muscular chest wall pain was significantly related to reporting exercise bra discomfort.  
Considering this link, and given that breast cancer surgery side effects are common and may 
persist for many years post surgery [35], there is clear need for further investigation into 
specialised breast support designs for women following surgery for breast cancer, who wish to 
reap the health benefits associated with exercise. 
Radiotherapy Side Effects 
The physical side effects of broken and painful ribs, as well as burning, sensitive skin and/or 
chafing, are typically linked to radiation therapy [17]. For the remainder of their lives, breast 
cancer survivors who have undergone radiation therapy are also at risk of developing long-
term radiation effects such as lymphoedema, shoulder limitations and fibrosis [17]. Acute skin 
reactions due to radiation therapy are primarily due to a damaging effect on the basal layer of 
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the epidermis [22]. Within three months of radiation, 61% of the patients report erythema, and 
55% report pain and tenderness of the skin or breast [22]. Even six months after radiation, up 
to 44% of patients still experience pain and tenderness in the breast region, and up to 25% 
report erythema [22]. It has been suggested that radiation effects have the same frequency and 
intensity regardless of the type of surgery undergone, and acute and late radiation-related 
morbidities are independent adverse effects, without a mechanistic relationship [23]. Factors 
such as treatment technique, beam energy, bra cup size and dose variation across the target 
volume all have a significant effect on the acute skin reaction observed [24]. 
The axilla and inframammary fold are commonly the sites of the most severe skin injury 
following radiation therapy [25].  The band of an exercise bra provides the primary support 
for the breasts, and will sit on these sites, which may lead to greater discomfort as a result of 
bra band pressure on the skin and underlying hypodermis. Therefore, exercise bras for breast 
cancer survivors must account for and minimise the exacerbation of this radiation damage by 
minimising the bra band pressure experienced at these sites. 
In some cases, an early skin reaction to radiation therapy can progress to a chronic injury. A 
common chronic skin condition following breast cancer radiation is fibrosis, which is 
characterised by an increase in “stiffness” or loss of compliance in the soft tissue [26, 27]. 
Fibrosis is typically permanent, and in skin, subcutis, and muscle, fibrosis can cause 
limitations in the range of motion and substantially affect function [26, 27]. This late effect of 
fibrosis has implications for exercise bra design for women following radiation therapy for 
breast cancer, as a “stiffer” breast may impair natural breast motion. An exploratory 
biomechanical study [28] found that, compared to the unaffected breast, the natural affected 
breast of four lumpectomy patients moved in an altered and restricted pattern when they ran 
on a treadmill, which was perceived by the participants as asymmetrical breast motion. We 
postulate that a prosthetic or reconstructed breast will also display motion changes, which 
may be detected by patients. These asymmetrical breast motion patterns are not accounted for 
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in bras worn during exercise by breast cancer survivors, and thereby may result in exercise bra 
discomfort, or self-consciousness, which may be interpreted as feeling ‘uncomfortable’ in the 
bra.  In fact, breast cancer survivors frequently report a fear of their prosthesis moving or 
falling out of their bra, which may be exacerbated by exercise, and excessive asymmetrical 
breast movement may draw unwanted attention to the survivor [29, 30]. Further study is 
therefore urgently required in order to ensure exercise bras designed for women treated for 
breast cancer account for the differences in movement likely to be displayed by the affected 
breast or prosthesis compared to the natural breast of these women.   
The present study also found respondent weight gain was significantly linked to exercise bra 
discomfort. Weight gain is a common side effect of breast cancer treatment and carries with it 
an increased risk of secondary cancer, and the development of other morbidities [17, 31]. 
Weight gain is also associated with a change in body composition and an increase in body 
weight without concurrent increases in lean muscle mass (sarcopenic obesity) [17, 31]. 
Women who gain weight following breast cancer treatment often find asymmetrical gains 
between their affected and unaffected side, and this is even more poignant for women who use 
a prosthesis as a result of breast tissue removal [30]. As a result, fluctuations in weight will 
affect how balanced a survivor feels towards her unaffected side, and will also change the fit 
of a bra. Specifically, breast cancer survivors have reported difficulty matching the affected or 
unaffected breast, and/or prosthesis cup sizes within a bra [28].   Correct bra fit is imperative 
in order to achieve exercise bra comfort [36], which may explain why women treated for 
breast cancer who report weight gain also report exercise bra discomfort. 
Strengths and Limitations 
We acknowledge that the primary limitation of this study is that the exercise data are based on 
self-reported measures. Demographic data regarding marital status, income, education level, 
region or residence (regional/remote or metropolitan), as well as data regarding exercise 
behaviours prior to treatment for breast cancer, were not collected, and therefore could not be 
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controlled for in the analysis of exercise behaviour. As this is the first study to investigate 
exercise bra discomfort and exercise levels among women living with breast cancer, the study 
was limited in the comparisons that could be made to existing literature specific to this field of 
research. Finally, we acknowledge that the coding of side effects into “no symptoms” versus 
“any level of that symptom” was broad. However, division into categories that accounted for 
the extent of symptom experience (none, mild to moderate, moderate to severe) was not 
feasible due to a limited distribution of respondents across the spectrum of symptom 
experience. Furthermore, even with this broad level of coding, the sub-sample sizes of these 
side effects were lower than what was deemed sufficient by a conservative proportional 
sample size calculation, and may limit the significance of these findings. Future studies with a 
larger study population, which can draw meaningful sub-sample sizes would be required to 
achieve this level of analysis. Future research should also gather greater details of which parts 
of the bra cause discomfort for women treated for breast cancer. Despite these limitations, this 
study provides valuable insight into an otherwise limited research area. The strengths of the 
study are that the online survey completion rate was very high (89.6%), providing responses 
from a large sample of Australian women treated for breast cancer.  Furthermore, the 
electronic nature of survey delivery allowed for side effect items to be randomised preventing 
any ordering bias; and limited the human error potential, which is present during manual 
paper-survey data transcriptions into electronic statistical packages.   
Conclusion 
This study links the reporting of exercise bra discomfort to not achieving recommended levels 
of exercise among women treated for breast cancer. This study also suggests that the physical 
side effects experienced as a result of breast cancer treatment are linked to experiencing bra 
discomfort during exercise.  Based on these findings it is postulated that providing better bra 
designs, which are specific to the needs of breast cancer survivors, may eliminate or reduce 
one of the important barriers to exercise. This, in turn, will enhance exercise participation in 
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this patient population and enable women treated for breast cancer to enjoy the health benefits 
associated with an active lifestyle. 
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Table 1: Respondents’ demographic information with comparisons to Australian population 
data. 
 Present Study Comparison Data (%) 
N % 
Health Status 428 Australian General Female Population [32] 
In general, would you say your health is: 
Excellent 55 12.9% 
57% [Excellent or Very Good] 
Very good 167 39.0% 
Good 150 35.0% 29% [Good] 
Fair 44 10.3% 
14% [Fair or Poor] 
Poor 6 1.4% 
Missing data 4 0.9% 
State or Territory 428 Australian Breast Cancer Population [33] 
What is your postcode? 
New South Wales 114 26.6% 34% 
Victoria 119 27.8% 25% 
Queensland 65 15.2% 18% 
Western Australia 26 6.1% 9% 
South Australia 41 9.6% 9% 
Tasmania 15 3.5% 2% 
Australian Capital Territory 44 10.3% 2% 
Northern Territory 4 0.9% 0% 
Missing data 4 0.9% 
Age 432  Australian Breast Cancer Population [33] 
What is your date of birth?  
<30 years old 2 0.5% 0% 
30-49 years old 142 32.9% 12% 
50-69 years old 271 62.7% 51% 
70+ years old 17 3.9% 37% 
Missing data 0   
    
Exercise 423 Age-matched Australian Female Population [34] 
Sufficiently Active 158 36.5% 37.6% 
Missing data 9 2.2% 
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Table 2:  Respondents’ characteristics divided into binary logistic regression groups. 
Binary Logistic Regression Groups n % Categories 
    
Age 432   
What is your date of birth?    
    
<30 2 0.0% “Under 50 years old” 
n = 144; 33% 30-49 142 33.0% 
    
50-69 271 63.0% “50 years and over” 
n = 288; 67% 70+ 17 4.0% 
Exercise 423   
In a typical week, on how many days do you do [moderate-intensity or vigorous-intensity] sports, fitness or recreational 
activities? [Number of days per week] 
How much time do you spend doing [moderate-intensity or vigorous-intensity] sports, fitness or recreation ON A 
TYPICAL DAY? [Hours][Minutes] 
 
Insufficiently Active 265 61.3% “Insufficiently Active” 
    
Sufficiently Active 158 36.5% “Sufficiently Active” 
    
Missing data 9 2.2%  
Surgery undergone 429   
Please indicate ALL the surgeries you have undergone for your breast cancer.  If you have not undergone any surgery, 
please skip this question. [Lumpectomy][Mastectomy] with [Right][Left] 
 
Unilateral lumpectomy 179 41.4% “Lumpectomy” 
n = 188; 43.5% Double lumpectomy 9 2.1% 
    
Unilateral lumpectomy followed by mastectomy 75 17.4% 
“Mastectomy” 
n = 241; 55.8% 
Double lumpectomy followed by mastectomy 24 5.6% 
Unilateral mastectomy 107 24.8% 
Double mastectomy 35 8.1% 
    
Missing data 3 0.7%  
Time since completion of treatment 387   
Are you CURRENTLY undergoing any of the following treatments? [Chemotherapy][Radiotherapy][Hormonal therapies] 
For the treatments you have FINISHED, what was the date of your last session ever? [Month][Year] 
    
Current chemotherapy 14 3.2% “Currently undergoing  
treatment” 
n = 239 a; 55.3% 
Current radiotherapy 3 0.7% 
Current hormonal therapies 226 51.4% 
    
< 1 year 20 4.6% 
“ Finished  treatment” 
n = 148; 34.3% 
1 - 2 years 50 11.5% 
3 - 4 years 23 5.3% 
5 - 7 years 29 6.7% 
8 - 10 years 9 2.1% 
> 10 years 17 3.9% 
    
Mean (± S.D) years of treatment completion (excluding current Tx) 4.3 ± 4.2 years 
    
Missing data 45 10.4%  
a  Two respondents were simultaneously undergoing chemotherapy and hormonal therapies, while another two respondents 
were undergoing radiotherapy and hormonal therapies. 
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Table 3:  Group percentage numbers and binary logistic regression values (with Odds Ratio) 
of patient characteristics and exercise levels against reported bra discomfort.  
 
 Independent Variables 
Bra discomfort a 
Age 
Under 50 years old vs. 
50 years and over 
Surgery 
Lumpectomy vs. 
Mastectomy 
Current Treatment 
Current treatment vs. 
Finished treatment 
Exercise 
Insufficiently active vs. 
Sufficiently active 
Odds Ratio (95% CI) b 1.01 (0.65 – 1.58) 1.25 (0.81 – 1.92) 0.88 (0.58 – 1.35) 2.04* (1.32 – 3.16) 
 < 50 yr ≥ 50 yr Lumpectomy Mastectomy Current treatment 
Finished 
treatment 
Insufficiently 
active 
Sufficiently 
active 
Number reporting bra 
discomfort (%) 
64 (15%) 120 (28%) 76 (18%) 107 (25%) 106 (25%) 59 (14%) 133 (31%) 51 (12%) 
Number reporting no 
bra discomfort (%) 
74 (17%) 156 (36%) 105 (24%) 123 (28%) 126 (29%) 82 (19%) 125 (29%) 105 (24%) 
Data missing 18 (4%) 21 (5%) 59 (13%) 18 (4%) 
a  “Do parts of the bra you wear during exercise cause you discomfort?”; closed-ended response question, “Yes” or “No” 
response options. 
b  OR = 1: event equally likely in both groups; OR > 1: event more likely in first group; OR < 1, event more likely in second 
group. 
*  p = 0.04 
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Figure 1: Proportion of women who reported experiencing exercise bra discomfort and the 
associated physical side effects. 
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